248 related articles for article (PubMed ID: 8600307)
21. Synaptic vesicle protein 2B is expressed in podocyte, and its expression is altered in proteinuric glomeruli.
Miyauchi N; Saito A; Karasawa T; Harita Y; Suzuki K; Koike H; Han GD; Shimizu F; Kawachi H
J Am Soc Nephrol; 2006 Oct; 17(10):2748-59. PubMed ID: 16943307
[TBL] [Abstract][Full Text] [Related]
22. Early changes in gene expression that influence the course of primary glomerular disease.
Clement LC; Liu G; Perez-Torres I; Kanwar YS; Avila-Casado C; Chugh SS
Kidney Int; 2007 Aug; 72(3):337-47. PubMed ID: 17457373
[TBL] [Abstract][Full Text] [Related]
23. Macrophagic cells outgrowth from normal rat glomerular culture: possible metaplastic change from podocytes.
Orikasa M; Iwanaga T; Takahashi-Iwanaga H; Kozima K; Shimizu F
Lab Invest; 1996 Nov; 75(5):719-33. PubMed ID: 8941217
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis.
Hayashi K; Horikoshi S; Osada S; Shofuda K; Shirato I; Tomino Y
J Pathol; 2000 Jul; 191(3):299-305. PubMed ID: 10878552
[TBL] [Abstract][Full Text] [Related]
25. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
26. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits.
Tipping PG; Leong TW; Holdsworth SR
Lab Invest; 1991 Sep; 65(3):272-9. PubMed ID: 1890807
[TBL] [Abstract][Full Text] [Related]
28. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Atkins RC
Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
[TBL] [Abstract][Full Text] [Related]
29. Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
Nephrology (Carlton); 2005 Apr; 10(2):167-73. PubMed ID: 15877677
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
Holdsworth SR; Tipping PG
J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
Erlich JH; Holdsworth SR; Tipping PG
Am J Pathol; 1997 Mar; 150(3):873-80. PubMed ID: 9060825
[TBL] [Abstract][Full Text] [Related]
32. Hageman factor in experimental nephrotoxic nephritis in the rabbit.
Wiggins RC
Lab Invest; 1985 Sep; 53(3):335-48. PubMed ID: 3928966
[TBL] [Abstract][Full Text] [Related]
33. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.
Rovin BH; Rumancik M; Tan L; Dickerson J
Lab Invest; 1994 Oct; 71(4):536-42. PubMed ID: 7967509
[TBL] [Abstract][Full Text] [Related]
34. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury.
Allen AR; McHale J; Smith J; Cook HT; Karkar A; Haskard DO; Lobb RR; Pusey CD
J Immunol; 1999 May; 162(9):5519-27. PubMed ID: 10228033
[TBL] [Abstract][Full Text] [Related]
35. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis.
Meyer-Schwesinger C; Dehde S; Klug P; Becker JU; Mathey S; Arefi K; Balabanov S; Venz S; Endlich KH; Pekna M; Gessner JE; Thaiss F; Meyer TN
J Immunol; 2011 Sep; 187(6):3218-29. PubMed ID: 21844386
[TBL] [Abstract][Full Text] [Related]
36. The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy.
Thomson NM; Holdsworth SR; Glasgow EF; Atkins RC
Am J Pathol; 1979 Feb; 94(2):223-40. PubMed ID: 371409
[TBL] [Abstract][Full Text] [Related]
37. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
38. Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model.
Polihronis M; Murphy BF; Pearse MJ; Power DA
Exp Nephrol; 1996; 4(5):271-8. PubMed ID: 8931982
[TBL] [Abstract][Full Text] [Related]
39. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors.
Silva FG; Hoyer JR; Pirani CL
Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880
[TBL] [Abstract][Full Text] [Related]
40. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
Le Hir M; Haas C; Marino M; Ryffel B
Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
